A study to compare the clinical efficacy & safety of equal doses of Hyperbaric ropivacaine vs Hyperbaric bupivacaine for sub arachnoid block in knee arthroscopic surgery.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: S832- Tear of meniscus, current injuryHealth Condition 2: S832- Tear of meniscus, current injury
- Registration Number
- CTRI/2023/09/057327
- Lead Sponsor
- FORTIS HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Willing to participate,
ASA grade 1 and 2,
Age- 16-65 years,
Either gender scheduled for elective knee arthroscopic surgery under spinal anaesthesia,
Pt with BMI less then 35,
Patients who have given valid informed written consent.
Exclusion Criteria
Patients of American society of Anaesthesiologists 3 and 4,
Patient refusal ,
Infection at the site of administration,
Coagulopathy ,
Spinal deformity,
Allergic to local anesthetic drugs ,
Lack of informed written consent ,
Duration of surgery greater than 120 mins,
Patients having allergy to study drug,
Patients with psychiatric disorder or history of drug abuse.
Patient unable to comprehend,
Morbidly obese patients (BMI greater than 35kg per m2),
Pregnant patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the clinical efficacy & safety of equal doses 3ml of 0.75 % Hyperbaric ropivacaine with 3ml of 0.5% Hyperbaric bupivacaine for sub arachnoid block in knee arthroscopic surgery for a duration of 16 to 18 months <br/ ><br> <br/ ><br>Timepoint: 1.The onset of Sensory block till T 10 <br/ ><br>2.The onset of Motor block. <br/ ><br>3.Time for two segment regression of sensory block <br/ ><br>4.The complete duration of sensory & motor block <br/ ><br>5.Intraoperative Haemodynamics. <br/ ><br>6.Intraoperative complications. <br/ ><br>7.Time to first rescue analgesic. <br/ ><br>8.Time to micturition. <br/ ><br>for a duration of 16 to 18 months
- Secondary Outcome Measures
Name Time Method To study & compare the side effect profile of the two drugs, <br/ ><br>To study the intraoperative and post operative complications. <br/ ><br>Timepoint: Intraoperative vitals at 1min, 5min,10min,15min,20min,25min,30min,45min,60min,75min,90min,120min <br/ ><br>Post operative vitals at 0min,30min,1hr,1.5hr,2hr,2.5hr,3hr.